What are the benefits of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction?
Primary angioplasty has been shown to significantly reduce mortality and improve long-term outcomes in patients with acute myocardial infarction compared to thrombolytic therapy. Studies such as the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy and the Zijlstra F et al. study have demonstrated that primary angioplasty is associated with a lower mortality rate than thrombolytic therapy. Additionally, primary angioplasty has also been found to be more effective in reducing risk of reinfarction, stroke, and heart failure compared to thrombolytic therapy. 